Get more information on Medical Tourism Market - Request Free Sample Report
The Medical Tourism Market Size was valued at USD 10.78 Billion in 2023, and is expected to reach USD 70.18 Billion by 2032, and grow at a CAGR of 24.52% over the forecast period 2024-2032.
The global medical tourism market is poised to expand in the next few years. The medical tourism market is expanding with an increase in healthcare technology, greater accessibility, and growing demand for desired treatment internationally. The advent of high health service costs in home countries is the major factor boosting market growth. Increasing emphasis on R&D for the development of innovative healthcare is anticipated to drive market growth over the forecast period. In the coming decade, it is estimated that developing countries will also cater to patients from outside their nation seeking for state of art treatments such as robotic surgery and oncology treatment, etc. In March 2023, the Medical Tourism Association along with Global Healthcare Resources and The International Healthcare Research Center launched its inaugural Medical Tourism Moonshot to help dismantle big obstacles standing in the way of greater expansion for medical tourism. These initiatives, to help in the advancement of medical devices are expected to further increase the tourist footfall for advanced healthcare services and thereby sustain the growth of the market.
MARKET DYNAMICS:
KEY DRIVERS:
Availability of Latest Medical Technologies and High Quality of Service Are Significant Drivers for The Medical Tourism Market.
Growing Compliance of International Quality Standards Drives the Medical Tourism Market.
RESTRAINTS:
Issues with Patient Follow-Up and Post-procedure Complications are a Significant Restraint Hampering the Growth of the Market
Medical Record Transfer Issues are Limiting the Growth of the Medical Tourism Market.
OPPORTUNITY:
Expanding International Healthcare Networks and Partnerships Create Opportunities for Hospitals and Clinics to Attract a Global Patient Base.
Countries With Favorable Regulatory Environments and Partnerships with International Insurance Companies Can Boost Medical Tourism by Providing Seamless Access and Financing Options for Foreign Patients.
By Treatment Type
The growing self-awareness about aesthetic appearance and rising demand for cosmetic procedures are the major drivers for the cosmetic treatment type growth that hold 30% in 2023. Additionally, people are opting more for these procedures in some other countries primarily due to the high cost of cosmetic procedures in their country. For example, according to the data published by the International Society of Aesthetic Plastic Surgery, almost 14.98 million surgical and 18.86 million non-surgical cosmetic procedures were performed globally in 2022. The highest number of procedures was reported in the age group of 35 to 50 years which is approximately 4.4 million procedures, followed by 18 to 34 years which is around 2.2 million procedures. According to the same source, the top five countries with the highest numbers of cosmetic surgical procedures in 2022 were the United States, Brazil, Mexico, Turkey, and Colombia. The first country has the highest number of procedures due to the presence of a sophisticated healthcare system and the presence of a large number of plastic surgeons.
Additionally, governments and companies are spending heavily to develop the medical tourism industry and attract cosmetic medical tourism in the native country. This factor is also expected to drive the cosmetic medical tourism market growth because new investments and the introduction of more new companies to the market will have more investments and launch that will result in more improvement in the infrastructure that will lead to more inflow of medical tourists seeking cosmetic treatment. For example, in March 2023, in Indonesia, GC Bio group launched its medical aesthetic clinic NULOOK on Bali Island to provide all-encompassing K-beauty aesthetic procedures grounded on bio-medical technology and brand name the island as a prominent cosmetic medical tourism destination. Similarly, in July 2023, in India, India’s SPARSH Group of Hospitals launched its most recent high-tech medical department – The Institute of Cosmetic Surgery and Cosmetology to provide world-class all-inclusive medical care for aesthetic medicine and attract medical tourists seeking aesthetic medicine procedures in India.
In 2023, North American Medical Tourism market share is held by 40%. The presence of a large number of healthcare institutions that are well equipped is expected to drive the market in North America. It is more than 6,120 hospitals in the United States as of the American Hospital Association 2024. Likewise, the Canadian government site states that there were 779 medical and surgical hospitals across the nation in May of 2022. This extensive network of hospitals gave rise to medical tourism attracting patients for availing of advanced healthcare treatments thus propelling the market growth.
This is likely to accelerate the growth of the market over time for the assessment period with increasing efforts and investments from major industry participants as well as governments. Moreover, government funding to develop healthcare facilities in the region is anticipated as one of the factors that could fuel market growth during the forecast period. An additional USD 33.60 billion was spent to enhance healthcare services in February of 2023 by the Canadian government.
Get Customized Report as per your Business Requirement - Request For Customized Report
The key market players are Raffles Medical Group, MOHW Hengchun Tourism Hospital, Fortis Healthcare, Bumrungrad International Hospital, Livonia Global, Asian Heart Institute, Apollo Hospitals Enterprise Ltd., Mount Elizabeth Hospitals, Gleneagles Hospitals, KPJ Healthcare Berhad & other players.
Health Tourism Abroad - Health and Wellness Destination - A new platform compatible with top-of-the-line medical facilities, global healthcare services & luxury tourism experiences was launched as an official introduction in June 2024. It aims at becoming the top healthcare destination for patients in need of high quality& affordable treatment overseas.
The gifting brand Ferns N Petals announced the launch of its global medicinal tourism division 'MediJourney' in Jan 2024. MediJourney is changing the game in healthcare support to empower individual health and well-being on a global scale. MediJourney is an all-in-one platform to support any healthcare facility, including doctor consultation, medical visa assistance, or Telemedicine services followed by post-treatment follow-up.
In September 2023, Alibaba Japan began offering a medical tourism service for Chinese tourists in cooperation with the Japanese national hospital using 'Tmall Global,' an overseas EC platform opened by The Alibaba Group. It starts with a health checkup or medical screening program. Alibaba was the first one to build their official shop on Tmall Global and directly provide booking options to consumers.
DarwinAI was born on July 2023 by the Medical Tourism Association, as a new cutting-edge AI-based marketing technology for the medical travel and tourism industry. Innovatively, Darwin AI leverages advanced AI algorithms to enhance branding and move beyond the echo systemic effect of brand names.
| Report Attributes | Details |
| Market Size in 2023 | US$ 10.78 Billion |
| Market Size by 2032 | US$ 70.18 Billion |
| CAGR | CAGR of 24.52% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Treatment Type (Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedics Treatment, Bariatric Treatment, Infertility Treatment, Ophthalmic Treatment, and Others) •By Service Provider (Public & Private) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Raffles Medical Group, MOHW Hengchun Tourism Hospital, Fortis Healthcare, Bumrungrad International Hospital, Livonia Global, Asian Heart Institute, Apollo Hospitals Enterprise Ltd., Mount Elizabeth Hospitals, Gleneagles hospitals, KPJ Healthcare Berhad & other players |
| Key Drivers | •Availability of Latest Medical Technologies and High Quality of Service Are Significant Drivers for The Medical Tourism Market. •Growing Compliance of International Quality Standards Drives the Medical Tourism Market. |
| RESTRAINTS | •Issues with Patient Follow-Up and Post-procedure Complications are a Significant Restraint Hampering the Growth of the Market •Medical Record Transfer Issues are Limiting the Growth of the Medical Tourism Market. |
Ans: The Medical Tourism Market was valued at USD 10.78 Billion in 2023.
Ans: The expected CAGR of the Global Medical Tourism Market during the forecast period is 24.52%.
Ans The Cosmetic Treatment held the largest share in the Medical Tourism Market in 2023.
Ans: The Medical Tourism Market will be valued at USD 70.18 Billion in 2032.
Ans: The U.S. led Medical Tourism in the North American region with the highest revenue share in 2023.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Medical Tourism Market Segmentation, by Treatment Type
7.1 Chapter Overview
7.2 Cardiovascular Treatment
7.2.1 Cardiovascular Treatment Market Trends Analysis (2020-2032)
7.2.2 Cardiovascular Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Orthopedic Treatment
7.3.1 Orthopedic Treatment Market Trends Analysis (2020-2032)
7.3.2 Orthopedic Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Cosmetic Treatment
7.4.1 Cosmetic Treatment Market Trends Analysis (2020-2032)
7.4.2 Cosmetic Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Bariatric Treatment
7.5.1 Bariatric Treatment Market Trends Analysis (2020-2032)
7.5.2 Bariatric Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Dental Treatment
7.6.1 Dental Treatment Market Trends Analysis (2020-2032)
7.6.2 Dental Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Ophthalmology Treatment
7.7.1 Ophthalmology Treatment Market Trends Analysis (2020-2032)
7.7.2 Ophthalmology Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.8 Infertility Treatment
7.8.1 Infertility Treatment Market Trends Analysis (2020-2032)
7.8.2 Infertility Treatment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.9 Others
7.9.1 Others Market Trends Analysis (2020-2032)
7.9.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Medical Tourism Market Segmentation, by Service Provider
8.1 Chapter Overview
8.2 Public
8.2.1 Public Market Trends Analysis (2020-2032)
8.2.2 Public Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Private
8.3.1 Private Market Trends Analysis (2020-2032)
8.3.2 Private Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North Americ Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.2.4 North America Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.2.6 USA
9.2.6.1 USA Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.2.6.2 USA Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.2.7 Canada
9.2.7.1 Canada Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.2.7.2 Canada Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.2.8 Mexico
9.2.8.1 Mexico Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.2.8.2 Mexico Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.1.6 Poland
9.3.1.6.1 Poland Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.1.6.2 Poland Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.1.7 Romania
9.3.1.7.1 Romania Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.1.7.2 Romania Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.1.8 Hungary
9.3.1.8.1 Hungary Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.1.8.2 Hungary Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.1.9 Turkey
9.3.1.9.1 Turkey Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.1.9.2 Turkey Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.6 Germany
9.3.2.6.1 Germany Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.6.2 Germany Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.7 France
9.3.2.7.1 France Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.7.2 France Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.8 UK
9.3.2.8.1 UK Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.8.2 UK Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.9 Italy
9.3.2.9.1 Italy Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.9.2 Italy Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.12 Switzerland
9.3.2.12.1 Switzerland Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.12.2 Switzerland Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.13 Austria
9.3.2.13.1 Austria Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.13.2 Austria Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.3.2.14 Rest of Western Europe
9.3.2.14.1 Rest of Western Europe Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.3.2.14.2 Rest of Western Europe Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.6 China
9.4.6.1 China Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.6.2 China Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.7 India
9.4.7.1 India Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.7.2 India Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.8 Japan
9.4.8.1 Japan Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.8.2 Japan Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.9 South Korea
9.4.9.1 South Korea Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.9.2 South Korea Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.9 Vietnam
9.4.9.1 Vietnam Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.9.2 Vietnam Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.10 Singapore
9.4.10.1 Singapore Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.10.2 Singapore Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.12 Australia
9.4.12.1 Australia Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.12.2 Australia Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.4.13 Rest of Asia Pacific
9.4.13.1 Rest of Asia Pacific Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.4.13.2 Rest of Asia Pacific Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.1.6 UAE
9.5.1.6.1 UAE Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.1.6.2 UAE Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.1.7 Egypt
9.5.1.7.1 Egypt Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.1.7.2 Egypt Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.1.8 Saudi Arabia
9.5.1.8.1 Saudi Arabia Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.1.8.2 Saudi Arabia Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.1.9 Qatar
9.5.1.9.1 Qatar Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.1.9.2 Qatar Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.2.4 Africa Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.2.6 South Africa
9.5.2.6.1 South Africa Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.2.6.2 South Africa Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.2.7 Nigeria
9.5.2.7.1 Nigeria Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.2.7.2 Nigeria Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.5.2.8 Rest of Africa
9.5.2.8.1 Rest of Africa Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.5.2.8.2 Rest of Africa Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Medical Tourism Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.6.4 Latin America Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.6.6 Brazil
9.6.6.1 Brazil Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.6.6.2 Brazil Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.6.7 Argentina
9.6.7.1 Argentina Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.6.7.2 Argentina Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.6.8 Colombia
9.6.8.1 Colombia Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.6.8.2 Colombia Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
9.6.9 Rest of Latin America
9.6.9.1 Rest of Latin America Medical Tourism Market Estimates and Forecasts, by Treatment Type (2020-2032) (USD Billion)
9.6.9.2 Rest of Latin America Medical Tourism Market Estimates and Forecasts, by Service Provider (2020-2032) (USD Billion)
10. Company Profiles
10.1 Raffles Medical Group
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 MOHW Hengchun Tourism Hospital
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Fortis Healthcare
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Bumrungrad International Hospital
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Livonta Global
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Asian heart Institute
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Apollo Hospitals Enterprise Ltd.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Mount Elizabeth Hospitals
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Gleneagles hospitals
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 KPJ Healthcare Berhad
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Treatment Type
Cardiovascular Treatment
Orthopedic Treatment
Cosmetic Treatment
Bariatric Treatment
Dental Treatment
Ophthalmology Treatment
Infertility Treatment
Others
By Service Provider
Public
Private
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Functional Service Providers (FSP) Market Size was valued at USD 14.68 billion in 2023, and is expected to reach USD 30.70 billion by 2032, and grow at a CAGR of 8.56% over the forecast period 2024-2032.
The Wheelchair Market size was estimated at USD 5.04 billion in 2023 and is expected to reach USD 9.58 billion by 2032 at a CAGR of 7.4% from 2024 to 2032.
The Dyspnea Treatment Market Size was valued at USD 6.16 Billion in 2023 and is expected to reach USD 11.01 Billion by 2032 and grow at a CAGR of 6.95% over the forecast period 2024-2032.
The Bronchoscopy Market was valued at USD 2.83 billion in 2023 and is expected to reach USD 5.71 billion by 2032, growing at a CAGR of 8.15% from 2024-2032.
The Molecular Quality Controls Market size was estimated at USD 0.1 billion in 2023 and is expected to reach USD 0.16 billion by 2031 with a growing CAGR of 6.7% during the forecast period of 2024-2031.
The Erectile Dysfunction Treatment Devices Market is expected to grow from USD 1.58 billion in 2023 to USD 3.43 billion by 2032, at a compound annual growth rate of 9.03% during the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
